Pacira Biosciences Inc at JPMorgan Healthcare Conference Transcript
Hi, everybody. Welcome to day 3 of the JPMorgan Healthcare Conference. My name is Hardik Parikh. I work in the equity research team covering large cap biopharma for U.S. I want to welcome Frank Lee, the freshly minted CEO of Pacira up to the floor.
Thanks, Hardik and good morning, everybody. After what 5 days on the job, I can tell you, I've got it almost figured out, give me another day.
I thought I'd start with a little bit of a bio about myself and maybe answer the question that many of you have, which is why Pacira. Why Pacira, Frank? And so just a little bit of bio, 30-plus years in the industry, most recently as CEO of Forma Therapeutics. We took a company there. I took over the reins from a CEO founder, who've been there a while. We pivoted the company, built a great team and took the company public. And after a while, a company by the name of Novo Nordisk took interest and acquired the company about a year ago. So that was most recently. And prior to that, I spent a lot of time
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |